ID   ADH4_RAT                Reviewed;         377 AA.
AC   Q64563;
DT   29-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   02-OCT-2024, entry version 140.
DE   RecName: Full=All-trans-retinol dehydrogenase [NAD(+)] ADH4 {ECO:0000305};
DE            EC=1.1.1.105 {ECO:0000269|PubMed:17279314};
DE   AltName: Full=Alcohol dehydrogenase 2 {ECO:0000303|PubMed:17279314};
DE   AltName: Full=Alcohol dehydrogenase 4;
DE   AltName: Full=Alcohol dehydrogenase class II;
DE            Short=Alcohol dehydrogenase II;
GN   Name=Adh4 {ECO:0000312|RGD:71028};
GN   Synonyms=Adh2 {ECO:0000303|PubMed:17279314};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=7635195; DOI=10.1016/0014-5793(95)00707-g;
RA   Hoeoeg J.-O.;
RT   "Cloning and characterization of a novel rat alcohol dehydrogenase of class
RT   II type.";
RL   FEBS Lett. 368:445-448(1995).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, AND CAUTION.
RX   PubMed=17279314; DOI=10.1007/s00018-007-6449-8;
RA   Hellgren M., Stroemberg P., Gallego O., Martras S., Farres J., Persson B.,
RA   Pares X., Hoeoeg J.O.;
RT   "Alcohol dehydrogenase 2 is a major hepatic enzyme for human retinol
RT   metabolism.";
RL   Cell. Mol. Life Sci. 64:498-505(2007).
CC   -!- FUNCTION: Catalyzes the NAD-dependent oxidation of either all-trans-
CC       retinol or 9-cis-retinol (PubMed:17279314). Also oxidizes long chain
CC       omega-hydroxy fatty acids, such as 20-HETE, producing both the
CC       intermediate aldehyde, 20-oxoarachidonate and the end product, a
CC       dicarboxylic acid, (5Z,8Z,11Z,14Z)-eicosatetraenedioate (By
CC       similarity). Also catalyzes the reduction of benzoquinones (By
CC       similarity). {ECO:0000250|UniProtKB:P08319,
CC       ECO:0000269|PubMed:17279314}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=all-trans-retinol + NAD(+) = all-trans-retinal + H(+) + NADH;
CC         Xref=Rhea:RHEA:21284, ChEBI:CHEBI:15378, ChEBI:CHEBI:17336,
CC         ChEBI:CHEBI:17898, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         EC=1.1.1.105; Evidence={ECO:0000269|PubMed:17279314};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21285;
CC         Evidence={ECO:0000305|PubMed:17279314};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=9-cis-retinol + NAD(+) = 9-cis-retinal + H(+) + NADH;
CC         Xref=Rhea:RHEA:42052, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:78272, ChEBI:CHEBI:78273;
CC         Evidence={ECO:0000269|PubMed:17279314};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42053;
CC         Evidence={ECO:0000305|PubMed:17279314};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=20-oxo-(5Z,8Z,11Z,14Z)-eicosatetraenoate + H2O + NAD(+) =
CC         (5Z,8Z,11Z,14Z)-eicosatetraenedioate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:39803, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:76645,
CC         ChEBI:CHEBI:76647; Evidence={ECO:0000250|UniProtKB:Q9QYY9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39804;
CC         Evidence={ECO:0000250|UniProtKB:Q9QYY9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=20-hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoate + NAD(+) = 20-
CC         oxo-(5Z,8Z,11Z,14Z)-eicosatetraenoate + H(+) + NADH;
CC         Xref=Rhea:RHEA:39799, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:76624, ChEBI:CHEBI:76645;
CC         Evidence={ECO:0000250|UniProtKB:Q9QYY9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39800;
CC         Evidence={ECO:0000250|UniProtKB:Q9QYY9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,4-benzoquinone + H(+) + NADH = hydroquinone + NAD(+);
CC         Xref=Rhea:RHEA:60660, ChEBI:CHEBI:15378, ChEBI:CHEBI:16509,
CC         ChEBI:CHEBI:17594, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000250|UniProtKB:Q9QYY9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60661;
CC         Evidence={ECO:0000250|UniProtKB:Q9QYY9};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000250};
CC   -!- ACTIVITY REGULATION: Oxidation of 20-HETE is inhibited by low
CC       concentrations of N-heptylformamide. Oxidation of 20-HETE is a
CC       decreased by 55-65% by either all-trans-retinol or all-trans-retinoic
CC       acid. Strongly inhibited by omega-hydroxy fatty acids.
CC       {ECO:0000250|UniProtKB:Q9QYY9}.
CC   -!- SUBUNIT: Dimer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Liver specific.
CC   -!- SIMILARITY: Belongs to the zinc-containing alcohol dehydrogenase
CC       family. Class-II subfamily. {ECO:0000305}.
CC   -!- CAUTION: Has a much lower NAD-retinol dehydrogenase activity compared
CC       to the human ortholog. {ECO:0000269|PubMed:17279314}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X90710; CAA62241.1; -; mRNA.
DR   PIR; S66286; S66286.
DR   AlphaFoldDB; Q64563; -.
DR   SMR; Q64563; -.
DR   CarbonylDB; Q64563; -.
DR   PhosphoSitePlus; Q64563; -.
DR   PaxDb; 10116-ENSRNOP00000016891; -.
DR   AGR; RGD:71028; -.
DR   RGD; 71028; Adh4.
DR   eggNOG; KOG0022; Eukaryota.
DR   InParanoid; Q64563; -.
DR   Reactome; R-RNO-5365859; RA biosynthesis pathway.
DR   Reactome; R-RNO-71384; Ethanol oxidation.
DR   PRO; PR:Q64563; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0004022; F:alcohol dehydrogenase (NAD+) activity; ISO:RGD.
DR   GO; GO:0004024; F:alcohol dehydrogenase (NAD+) activity, zinc-dependent; ISO:RGD.
DR   GO; GO:0004032; F:aldose reductase (NADPH) activity; ISO:RGD.
DR   GO; GO:0005503; F:all-trans retinal binding; ISO:RGD.
DR   GO; GO:0004745; F:all-trans-retinol dehydrogenase (NAD+) activity; ISS:UniProtKB.
DR   GO; GO:0019115; F:benzaldehyde dehydrogenase [NAD(P)+] activity; ISO:RGD.
DR   GO; GO:0051287; F:NAD binding; ISO:RGD.
DR   GO; GO:0003960; F:NADPH:quinone reductase activity; ISO:RGD.
DR   GO; GO:0016620; F:oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor; ISO:RGD.
DR   GO; GO:0019841; F:retinol binding; ISO:RGD.
DR   GO; GO:0051903; F:S-(hydroxymethyl)glutathione dehydrogenase (NAD(P)+) activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0046164; P:alcohol catabolic process; ISO:RGD.
DR   GO; GO:0006066; P:alcohol metabolic process; ISO:RGD.
DR   GO; GO:0006081; P:cellular aldehyde metabolic process; ISO:RGD.
DR   GO; GO:0006067; P:ethanol metabolic process; ISO:RGD.
DR   GO; GO:0010430; P:fatty acid omega-oxidation; ISS:UniProtKB.
DR   GO; GO:0046294; P:formaldehyde catabolic process; IBA:GO_Central.
DR   GO; GO:0042698; P:ovulation cycle; IEP:RGD.
DR   GO; GO:1901661; P:quinone metabolic process; ISO:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0001523; P:retinoid metabolic process; ISO:RGD.
DR   GO; GO:0042572; P:retinol metabolic process; ISS:UniProtKB.
DR   CDD; cd08299; alcohol_DH_class_I_II_IV; 1.
DR   Gene3D; 3.90.180.10; Medium-chain alcohol dehydrogenases, catalytic domain; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR013149; ADH-like_C.
DR   InterPro; IPR013154; ADH-like_N.
DR   InterPro; IPR002328; ADH_Zn_CS.
DR   InterPro; IPR011032; GroES-like_sf.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020843; PKS_ER.
DR   PANTHER; PTHR43880; ALCOHOL DEHYDROGENASE; 1.
DR   PANTHER; PTHR43880:SF14; ALL-TRANS-RETINOL DEHYDROGENASE [NAD(+)] ADH4; 1.
DR   Pfam; PF08240; ADH_N; 1.
DR   Pfam; PF00107; ADH_zinc_N; 1.
DR   SMART; SM00829; PKS_ER; 1.
DR   SUPFAM; SSF50129; GroES-like; 2.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   PROSITE; PS00059; ADH_ZINC; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Lipid metabolism; Metal-binding; NAD; Oxidoreductase;
KW   Reference proteome; Zinc.
FT   CHAIN           1..377
FT                   /note="All-trans-retinol dehydrogenase [NAD(+)] ADH4"
FT                   /id="PRO_0000160683"
FT   BINDING         47
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250"
FT   BINDING         48..49
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
FT   BINDING         68
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250"
FT   BINDING         98
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         101
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         104
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         112
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250"
FT   BINDING         179
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250"
FT   BINDING         204..209
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
FT   BINDING         228
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
FT   BINDING         233
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
FT   BINDING         297..299
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
FT   BINDING         320..322
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
FT   BINDING         372
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   377 AA;  40277 MW;  9944E04A86868CBF CRC64;
     MGTQGKVITC KAAIAWKTDS PLCIEEIEVS PPKAHEVRIK VIATCVCPTD INATNPKKKA
     LFPVVLGHEC AGIVESVGPG VTNFKPGDKV IPFFAPQCKK CKLCLSPLTN LCGKLRNFKY
     PTIDQELMED RTSRFTSKER SIYHFMGVSS FSQYTVVSEA NLARVDDEAN LERVCLIGCG
     FTSGYGAAIN TAKVTPGSAC AVFGLGCVGL SAVIGCKIAG ASRIIAIDIN SEKFPKAKAL
     GATDCLNPRD LDKPVQDVIT ELTGGGVDFS LDCAGTAQTL KAAVDCTVVG WGSCTVVGAK
     VDEMNISTVD MILGRSVKGT FFGGWKSVDS VPNLVTDYKN KKFDLDLLVT HALPFDKIND
     AIDLMNQGKS IRTILTF
//
